Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 105,634 shares at $69.71 ($7.4M) on 2017-11-02, disclosed to the SEC on 2017-11-06.
Open-market sale of $7.4M NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.71 | 7,518 | $524K | 7.1% |
| 2 | $69.71 | 7,518 | $524K | 7.1% |
| 3 | $69.71 | 45,299 | $3.2M | 42.9% |
| 4 | $69.71 | 45,299 | $3.2M | 42.9% |
| Total | $69.71 avg | 105,634 | $7.4M | 100% |
| Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |
| NBIX | SELL | 2017-07-31 | $437K | — | Filing → |